Publications (44) Publications in which a researcher has participated

2023

  1. A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study

    Respiratory Research, Vol. 24, Núm. 1

  2. Absence of High Lipoprotein(a) Levels Is an Independent Predictor of Acute Myocardial Infarction without Coronary Lesions

    Journal of Clinical Medicine, Vol. 12, Núm. 3

  3. Atrial Fibrillation and Diabetes Mellitus: Dangerous Liaisons or Innocent Bystanders?

    Journal of Clinical Medicine, Vol. 12, Núm. 8

  4. Bardet–Biedl Syndrome: An Uncommon Cause of Bronchiectasis

    Archivos de Bronconeumologia, Vol. 59, Núm. 12, pp. 831-832

  5. Benefits of dapagliflozin in the whole spectrum of heart failure in clinical practice: the RICA registry

    Future cardiology, Vol. 19, Núm. 6, pp. 323-332

  6. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269

  7. Claudin-3 Loss of Expression Is a Prognostic Marker in Castration-Resistant Prostate Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

  8. Clinical Outcomes of Critical COVID-19 in HIV-Infected Adults: A Propensity Score Matched Analysis

    Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 772-778

  9. Combining loop and thiazide diuretics for acute heart failure across the estimated glomerular filtration rate spectrum: A post-hoc analysis of the CLOROTIC trial

    European Journal of Heart Failure, Vol. 25, Núm. 10, pp. 1784-1793

  10. Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial

    European heart journal, Vol. 44, Núm. 5, pp. 411-421

  11. Complications after Prostate Cancer Treatment: Pathophysiology and Repair of Post-Radiation Urethral Stricture Disease

    Journal of Clinical Medicine, Vol. 12, Núm. 12

  12. Current heart failure disease management and treatment in accredited units from cardiology and internal medicine in Spain

    Revista Clinica Espanola, Vol. 223, Núm. 7, pp. 405-413

  13. Early and late onset cardiotoxicity following anthracycline-based chemotherapy in breast cancer patients: Incidence and predictors

    International Journal of Cardiology, Vol. 382, pp. 52-59

  14. Effect of Neuro-Adaptive Electrostimulation Therapy versus Sham for Refractory Urge Urinary Incontinence Due to Overactive Bladder: A Randomized Single-Blinded Trial

    Journal of Clinical Medicine, Vol. 12, Núm. 3

  15. Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis

    The European respiratory journal, Vol. 61, Núm. 3

  16. Evaluation of the Clinical Impact of Dapagliflozin Discontinuation as Adjunctive Therapy for Patients With Type 1 Diabetes After Indication Withdrawal: A Two-Center Retrospective Study

    Diabetes care, Vol. 46, Núm. 5, pp. e101-e102

  17. Executive summary of the 2023 update on the consensus regarding basic conduct during hospital admission for patients with acute heart failure

    Revista Clinica Espanola, Vol. 223, Núm. 8, pp. 499-509

  18. Factors Influencing Postoperative Overactive Bladder after Adjustable Trans-Obturator Male System Implantation for Male Stress Incontinence following Prostatectomy

    Journal of Clinical Medicine, Vol. 12, Núm. 24

  19. Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial

    European urology oncology, Vol. 6, Núm. 1, pp. 58-66

  20. Impact of the COVID-19 Pandemic on Cancer Diagnosis in Madrid (Spain) Based on the RTMAD Tumor Registry (2019–2021)

    Cancers, Vol. 15, Núm. 6